High-risk advanced ovarian cancer patients showed marginal survival benefit with bevacizumab added to first-line chemotherapy. Patients without high-risk characteristics did not show significant ...

Over the last decade, cloud computing has been a driver of cost savings over on-prem IT infrastructure and has become a leading source of IT spending. However, lately, this theory is being challenged ...